Dupilumab for hand eczema
暂无分享，去创建一个
[1] Wei Li,et al. Efficacy and safety of dupilumab for the treatment of adult atopic dermatitis: A meta-analysis of randomized clinical trials. , 2017, The Journal of allergy and clinical immunology.
[2] C. Langer,et al. Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer. , 2017, Lung cancer.
[3] P. Marchetti,et al. Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients , 2015, British Journal of Cancer.
[4] J. Johansen,et al. Hand eczema – prognosis and consequences: a 7‐year follow‐up study , 2014, The British journal of dermatology.
[5] T. Agner,et al. Hand eczema severity and quality of life: a cross‐sectional, multicentre study of hand eczema patients , 2008, Contact dermatitis.
[6] P. Schmid‐Grendelmeier,et al. The atopic eczema/dermatitis syndrome. Epidemiology, natural course, and immunology of the IgE-associated ("extrinsic") and the nonallergic ("intrinsic") AEDS. , 2003, Journal of investigational allergology & clinical immunology.